Johnson & Johnson
Sonia Driussi is a seasoned IT Manager with extensive experience in finance-related technology services, primarily within the Johnson & Johnson organization. Currently serving as the IT Manager and Finance Chapter Lead for JJT/Technology Services EMEA Supply Chain since January 2020, Sonia oversees EMEA cross-sectors ERP platforms. Prior roles include RSO EMEA SC Finance Support/Application Maintenance, where Sonia managed an offshore team and focused on finance applications, and IT Manager for Service Operations, responsible for application support for JDE One World platforms. Early career highlights include positions such as Senior Analyst at Ortho Clinical Diagnostics and Senior Functional Consultant at Proxima, coupled with accounting expertise from roles in financial management and support. Sonia holds a degree in Economics from Sapienza Università di Roma and a background in accounting and programming from Istituto “A. Ceccherelli.”
This person is not in any teams
This person is not in any offices
Johnson & Johnson
541 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.